In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Twist Bioscience Corp (NASDAQ: TWST) closed at $28.12 in the last session, down -2.50% from day before closing price of $28.84. In other words, the price has decreased by -$2.50 from its previous closing price. On the day, 1.75 million shares were traded. TWST stock price reached its highest trading level at $29.27 during the session, while it also had its lowest trading level at $28.02.
Ratios:
We take a closer look at TWST’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.90. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on December 13, 2024, initiated with a Outperform rating and assigned the stock a target price of $60.
On June 04, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $53.
Goldman Upgraded its Neutral to Buy on January 17, 2024, whereas the target price for the stock was revised from $25 to $45.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 04 ’25 when WERNER ROBERT F. sold 186 shares for $28.36 per share. The transaction valued at 5,276 led to the insider holds 49,780 shares of the business.
Leproust Emily M. sold 5,585 shares of TWST for $158,413 on Aug 04 ’25. The Chief Executive Officer now owns 639,721 shares after completing the transaction at $28.36 per share. On Aug 04 ’25, another insider, Green Paula, who serves as the SVP of Human Resources of the company, sold 1,255 shares for $28.36 each. As a result, the insider received 35,597 and left with 126,206 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TWST now has a Market Capitalization of 1697348608 and an Enterprise Value of 1539701248. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.69 while its Price-to-Book (P/B) ratio in mrq is 3.54. Its current Enterprise Value per Revenue stands at 4.25 whereas that against EBITDA is -12.889.
Stock Price History:
The Beta on a monthly basis for TWST is 2.31, which has changed by -0.36652398 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, TWST has reached a high of $55.33, while it has fallen to a 52-week low of $24.28. The 50-Day Moving Average of the stock is -17.19%, while the 200-Day Moving Average is calculated to be -29.86%.
Shares Statistics:
According to the various share statistics, TWST traded on average about 1.32M shares per day over the past 3-months and 2797920 shares per day over the past 10 days. A total of 60.17M shares are outstanding, with a floating share count of 57.32M. Insiders hold about 5.04% of the company’s shares, while institutions hold 111.25% stake in the company. Shares short for TWST as of 1753920000 were 10437018 with a Short Ratio of 7.89, compared to 1751241600 on 11033462. Therefore, it implies a Short% of Shares Outstanding of 10437018 and a Short% of Float of 19.510001.
Analysts are recommending an EPS of between -$2.32 and -$2.32 for the fiscal current year, implying an average EPS of -$2.32.
Revenue Estimates
According to 8 analysts, the current quarter’s revenue is expected to be $97.25M. It ranges from a high estimate of $97.96M to a low estimate of $96.73M. As of the current estimate, Twist Bioscience Corp’s year-ago sales were $84.71MFor the next quarter, 8 analysts are estimating revenue of $100.94M. There is a high estimate of $103.3M for the next quarter, whereas the lowest estimate is $99.04M.
A total of 8 analysts have provided revenue estimates for TWST’s current fiscal year. The highest revenue estimate was $375.52M, while the lowest revenue estimate was $374M, resulting in an average revenue estimate of $374.78M. In the same quarter a year ago, actual revenue was $312.97MBased on 8 analysts’ estimates, the company’s revenue will be $438.98M in the next fiscal year. The high estimate is $445.92M and the low estimate is $429.08M.